Eton Pharmaceuticals, Inc.

US$56.46As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ETONHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR 31.68%
Div yield —
ROE 90.62%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.83
PE TTM 35.31
TSR TTM 213.49%
Mkt cap US$1.628B
ROIC 84.44%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$72
27.07%
(35.03%)
Hold 6|10|6|2|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.93
0.92
1.00
1.11
15.13%
12.38%
19.22%
24.14%
Revenue$M
121.7
122.1
119.3
118.3
1.33%
3.55%
0.31%
1.86%
Peers (US$1.628B)
Cap (US$)
PE
1.461B
39.91x
1.428B
13.47x
1.629B
51.47x
Capital
TTM
5Y
10Y
Leveragex
5.253
0.641
0.640
EBIT/Intx
5.908
0.083
0.083
Own earn%
(34.16)
26.79
32.21
Sh yield%
32.93
6.54
8.21
Owners
Insiders/Inst%
0.52
69.21
Short interest%
0.83
SBC / revenue%
4.08
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
15–24
$1 testx
—
Incr. ROIC%
2